Page last updated: 2024-08-22

cladribine and B Virus Infection

cladribine has been researched along with B Virus Infection in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carroll, WM	1
Bosly, A; Delannoy, A; Ferrant, A; Filleul, B; Martiat, P; Michaux, JL; Mineur, P; Montfort, L; Straetmans, N; Van Den Neste, E; Vandercam, B	1
Lin, WC; Mann, KP; Moore, JO; Smith, C; Traweek, ST	1

Reviews

1 review(s) available for cladribine and B Virus Infection

Article	Year
Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection. Leukemia & lymphoma, 1999, Volume: 33, Issue:3-4 Topics: Antigens, CD; Antineoplastic Agents; Bone Marrow; CD8 Antigens; CD8-Positive T-Lymphocytes; Cladribine; Glomerulonephritis, IGA; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lymphoma, T-Cell; Male; Middle Aged; Postoperative Complications; Receptors, Antigen, T-Cell, gamma-delta	1999

Article

Year

Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection.

Leukemia & lymphoma, 1999, Volume: 33, Issue:3-4

Topics: Antigens, CD; Antineoplastic Agents; Bone Marrow; CD8 Antigens; CD8-Positive T-Lymphocytes; Cladribine; Glomerulonephritis, IGA; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lymphoma, T-Cell; Male; Middle Aged; Postoperative Complications; Receptors, Antigen, T-Cell, gamma-delta

1999

Other Studies

2 other study(ies) available for cladribine and B Virus Infection

Article	Year
Oral therapy for multiple sclerosis--sea change or incremental step? The New England journal of medicine, 2010, Feb-04, Volume: 362, Issue:5 Topics: Administration, Oral; Arrhythmias, Cardiac; Cladribine; Disease Progression; Female; Fingolimod Hydrochloride; Herpesviridae Infections; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Male; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine	2010
Infectious complications after 2-chlorodeoxyadenosine therapy. European journal of haematology, 1996, Volume: 56, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Cohort Studies; Disease Susceptibility; Female; Fever; Hematologic Diseases; Herpesviridae Infections; Humans; Immunologic Deficiency Syndromes; Incidence; Infections; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Risk Factors; Waldenstrom Macroglobulinemia	1996

Article

Year

Oral therapy for multiple sclerosis--sea change or incremental step?

The New England journal of medicine, 2010, Feb-04, Volume: 362, Issue:5

Topics: Administration, Oral; Arrhythmias, Cardiac; Cladribine; Disease Progression; Female; Fingolimod Hydrochloride; Herpesviridae Infections; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Male; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine

2010

Infectious complications after 2-chlorodeoxyadenosine therapy.

European journal of haematology, 1996, Volume: 56, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Cohort Studies; Disease Susceptibility; Female; Fever; Hematologic Diseases; Herpesviridae Infections; Humans; Immunologic Deficiency Syndromes; Incidence; Infections; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Risk Factors; Waldenstrom Macroglobulinemia

1996